GE HealthCare said revenue for Q3 was $4.9 billion, up 1% on both a reported and organic basis year over year, and net income attributable to GE HealthCare was $470 million versus $375 million a year earlier.

1. 01

   GE HealthCare said revenue for Q3 was $4.9 billion, up 1% on both a reported and organic basis year over year, and net income attributable to GE HealthCare was $470 million versus $375 million a year earlier.

2. 02

   The company said its net income margin for Q3 was 9.7% versus 7.8% a year earlier, and its Adjusted EBIT margin was 16.3% versus 15.4%. It attributed both margin measures to benefits from productivity and price.

3. 03

   GE HealthCare said cash flow from operating activities for Q3 was $742 million versus $650 million a year earlier, and free cash flow was $651 million versus $570 million.

4. 04

   The company said it set its full-year Adjusted EBIT margin outlook at 15.8% to 16.0% (prior outlook 15.7% to 16.0%) and its Adjusted EPS outlook at $4.25 to $4.35 (prior $4.20 to $4.35).

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.